Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Operating Expenses (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Operating Expenses for 16 consecutive years, with $11.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 44.97% to $11.8 million in Q4 2025 year-over-year; TTM through Nov 2025 was $31.1 million, a 9.04% increase, with the full-year FY2025 number at $31.1 million, up 9.04% from a year prior.
  • Operating Expenses was $11.8 million for Q4 2025 at Cryo Cell International, up from $5.9 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $24.1 million in Q4 2023 to a low of $5.2 million in Q2 2021.
  • A 5-year average of $7.7 million and a median of $6.7 million in 2023 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: soared 226.86% in 2023, then plummeted 66.13% in 2024.
  • Cryo Cell International's Operating Expenses stood at $8.1 million in 2021, then decreased by 9.42% to $7.4 million in 2022, then skyrocketed by 226.86% to $24.1 million in 2023, then tumbled by 66.13% to $8.1 million in 2024, then soared by 44.97% to $11.8 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Operating Expenses are $11.8 million (Q4 2025), $5.9 million (Q3 2025), and $6.4 million (Q2 2025).